NeurAxon raises $1.75 million from corporate investor Knight Therapeutics
NeurAxon has raised $1.75 million from Knight Therapeutics, a Montreal-based specialty pharmaceutical company, which will also provide additional funding to further development of the company's pharmaceuticals. Montreal-based NeurAxon has been a recipient of venture capital financing since 2004 and is a portfolio company of BDC Venture Capital, CTI Life Sciences, Delphi Ventures, HIG Ventures, NeuroVentures Capital, Five Corners Capital (Ventures West), and the Ontario Capital Growth Corporation.
2 January 2015•3 mins read
